ABIM HIGH YIELD | EXAM QUESTIONS AND ANSWERS|
COMPLETE STUDY GUIDE WITH 100% ACCURATE
QUESTIONS & ANSWERS! EXCELLENCE
GUARANTEED!
Course Code:
Course Title:
Programme:
Academic Year: 2026/2027.
Duration: 2 Hours.
Total Marks: 100.
Candidate Instructions:
1) Write your Registration Number on every answer booklet used.
2) Answer ALL questions in Section A and ANY TWO (2) questions in Section B.
3) Read each question carefully before answering.
4) Begin each question on a new page.
5) The marks for each question are indicated in brackets.
6) This paper consists of several printed pages, including this page.
7) Ensure your copy is complete before the examination begins.
8) Unauthorized materials and communication with other candidates are not permitted.
Turn Over.
APPHIA – Crafted with Care and Precision for Academic Excellence.
1
, Medications that improve survival in CHF Answer: - ACEI/ARB
- Carvedilol
- Metoprolol Succinate
- Hydralazine + Nitrates
- Spironolactone
- Neprilysin inhibitors
When to add beta blocker in CHF patients Answer: When they are euvolemic
Indications for AICD Answer: - EF less than or equal to 35% + NYHA Class 2 or 3
- EF less than or equal to 30% + NYHA Class 1
Indication for adding CRT (cardiac resynchronization therapy) to AICD Answer: QRS > 150
ms
Timeline to reassess EF for patients on guideline-directed therapy post MI Answer: 40 days
Timeline to reassess EF for patients on guideline-directed therapy in patients who are NOT post-
MI Answer: 3 months
When to add Entresto for CHF patients? Answer: At diagnosis
Limiting factor to adding Entresto Answer: Hypotension (SBP < 100)
What trial compared Entresto to ACEI? Answer: Paradigm
What is Ivabradine? Answer: Na channel inhibitor
When to add ivabradine Answer: CHF patient with HR > 70 despite maximal beta blocker
therapy
When to add SGLT-2 inhibitors in CHF patients Answer: - Low EF
- Persistently elevated BNP
- On optimal medical therapy
- Has AICD and CRT
SBP requirement to start SGLT-2 inhibitor in CHF pt Answer: SBP > 95
GFR requirement to start SGLT-2 inhibitor in CHF pt Answer: GFR > 30
Indications for AVR in AORTIC STENOSIS Answer: - Presence of symptoms (SAD,
presyncope)
- EF < 50% in an asymptomatic patient
APPHIA – Crafted with Care and Precision for Academic Excellence.
2
COMPLETE STUDY GUIDE WITH 100% ACCURATE
QUESTIONS & ANSWERS! EXCELLENCE
GUARANTEED!
Course Code:
Course Title:
Programme:
Academic Year: 2026/2027.
Duration: 2 Hours.
Total Marks: 100.
Candidate Instructions:
1) Write your Registration Number on every answer booklet used.
2) Answer ALL questions in Section A and ANY TWO (2) questions in Section B.
3) Read each question carefully before answering.
4) Begin each question on a new page.
5) The marks for each question are indicated in brackets.
6) This paper consists of several printed pages, including this page.
7) Ensure your copy is complete before the examination begins.
8) Unauthorized materials and communication with other candidates are not permitted.
Turn Over.
APPHIA – Crafted with Care and Precision for Academic Excellence.
1
, Medications that improve survival in CHF Answer: - ACEI/ARB
- Carvedilol
- Metoprolol Succinate
- Hydralazine + Nitrates
- Spironolactone
- Neprilysin inhibitors
When to add beta blocker in CHF patients Answer: When they are euvolemic
Indications for AICD Answer: - EF less than or equal to 35% + NYHA Class 2 or 3
- EF less than or equal to 30% + NYHA Class 1
Indication for adding CRT (cardiac resynchronization therapy) to AICD Answer: QRS > 150
ms
Timeline to reassess EF for patients on guideline-directed therapy post MI Answer: 40 days
Timeline to reassess EF for patients on guideline-directed therapy in patients who are NOT post-
MI Answer: 3 months
When to add Entresto for CHF patients? Answer: At diagnosis
Limiting factor to adding Entresto Answer: Hypotension (SBP < 100)
What trial compared Entresto to ACEI? Answer: Paradigm
What is Ivabradine? Answer: Na channel inhibitor
When to add ivabradine Answer: CHF patient with HR > 70 despite maximal beta blocker
therapy
When to add SGLT-2 inhibitors in CHF patients Answer: - Low EF
- Persistently elevated BNP
- On optimal medical therapy
- Has AICD and CRT
SBP requirement to start SGLT-2 inhibitor in CHF pt Answer: SBP > 95
GFR requirement to start SGLT-2 inhibitor in CHF pt Answer: GFR > 30
Indications for AVR in AORTIC STENOSIS Answer: - Presence of symptoms (SAD,
presyncope)
- EF < 50% in an asymptomatic patient
APPHIA – Crafted with Care and Precision for Academic Excellence.
2
